Avior Wealth Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,673
Closed -$238K 771
2025
Q3
$238K Hold
6,673
0.01% 656
2025
Q2
$384K Buy
6,673
+1,755
+36% +$99.2K 0.01% 507
2025
Q1
$287K Buy
4,918
+2,856
+139% +$195K 0.01% 560
2024
Q4
$166K Sell
2,062
-1,538
-43% -$131K 0.01% 752
2024
Q3
$288K Buy
3,600
+3,548
+6,823% +$252K 0.01% 598
2024
Q2
$3.18K Sell
52
-7
-12% -$416 ﹤0.01% 1854
2024
Q1
$2.92K Buy
+59
New +$2.81K ﹤0.01% 2208

Other funds holding PRCT

Avior Wealth Management's PRCT Position: Q4 2025 in Review

Avior Wealth Management sold out of Procept Biorobotics (PRCT) in Q4 2025, closing a stake of 6,673 shares — an estimated $238K sold.

Avior Wealth Management first reported a position in PRCT in Q1 2024 and held it in 7 quarters. The position peaked at $384K in Q2 2025. 263 funds tracked by Wall St. Rank hold PRCT as of Q4 2025.

  • Avior Wealth Management reported no remaining Procept Biorobotics position as of Q4 2025 after selling out during the quarter.
  • Avior Wealth Management sold 6,673 Procept Biorobotics shares in Q4 2025, an estimated $238K.
  • Avior Wealth Management first reported a position in Procept Biorobotics in Q1 2024 and held it in 7 quarters.
  • Avior Wealth Management's Procept Biorobotics position peaked at $384K in Q2 2025.
  • 263 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2025.

Based on Avior Wealth Management's 13F filing for Q4 2025, filed 6 Jan 2026.